Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Thermo Scientific Introduces Microplate Mover Swap Out Program

Published: Friday, May 31, 2013
Last Updated: Friday, May 31, 2013
Bookmark and Share
Maximizing up-time for automated laboratory platforms.

Thermo Fisher Scientific Inc. has announced the introduction of its new Swap Out Program for the Thermo Scientific™ Orbitor® RS microplate mover, to maximize up-time in automated workflows.

One of the main advantages of laboratory automation is increased productivity. The Orbitor RS achieves this with rapid and flexible plate handling, allowing loading of multiple stacked or high-density instruments within a compact footprint.

Supporting the robust and reliable technology of the Orbitor RS, the Thermo Scientific Swap Out Program guarantees quick and efficient instrument replacement in the unlikely event that performance drops.

This unique approach ensures researchers can rely on benefiting from the full potential of automation. In contrast, systems sourced from alternative vendors could be sat idle and unproductive for perhaps days or even weeks, during the often lengthy process of diagnosis, repair or replacement.

With the Swap Out Program, a replacement Orbitor RS instrument is dispatched within just 24 hours of the Thermo Fisher Scientific Support Department logging the service call.

Technicians will then promptly co-ordinate a site visit for swap-out, and ensure the complete system is up-and-running in the following four hours.

Unlike alternative automated systems, data is now stored on the accompanying computer, instead of on memory boards within the Orbitor RS itself.

This development is what makes the Swap Out Program possible, as externally stored data prevents loss during instrument replacement and eliminates the need to reprogram a new machine.

With the Thermo Scientific Orbitor RS Swap Out Program, laboratories relying upon automated systems can now experience full confidence in continued productivity.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Thermo Extends Collaboration with University of Birmingham
New Phenome Centre Birmingham, UK to use Thermo Scientific mass spectrometry instruments to advance metabolic phenotyping and metabolomics studies.
Tuesday, May 24, 2016
Thermo Fisher Completes Acquisition of Alfa Aesar
Thermo Fisher Scientific the world leader in serving science, has completed its previously announced acquisition of Alfa Aesar, a leading global manufacturer of research chemicals, from Johnson Matthey Plc, for £256 million (or approximately $400 million) in cash.
Friday, October 02, 2015
Thermo Fisher Scientific and Newman-Lakka Institute to Collaborate
The collaboration will research diagnostic approaches for personalized cancer treatment.
Tuesday, June 25, 2013
Scientific News
Stem Cells in Drug Discovery
Potential Source of Unlimited Human Test Cells, but Roadblocks Remain.
Automated Low Volume Dispensing Trends
Gain a better understanding of the current and future market requirements for fully automated LVD systems.
Protein-Based “Cancer Signature” Uncovered
Researchers investigated the expression of ribosomal proteins in human tissues and discovered a cancer type specific signature which could be used to predict the progression of the disease.
Ribosome Recycling as a Drug Target
Researchers explain mechanism that recycles bacterial ribosomes stalled on messenger RNAs that lack termination codons.
Predicting Leukaemia Development in Cancer Patients
Biomarker may predict which formerly treated cancer patients will develop highly fatal form of leukemia.
Survey of New York City Soil Uncovers Medicine-Making Microbes
Microbes have long been an invaluable source of new drugs. And to find more, we may have to look no further than the ground beneath our feet.
'Lab on the Skin' for Sweat Analysis
Northwestern University researchers develop a low-cost wearable electronic device that collects and analyzes sweat for health monitoring.
Cancer Signaling Pathway Illuminating Way To Therapy
Researchers refine a pro-growth signalling pathway, common to cancers, that can kill cancer cells while leaving healthy cells unharmed.
Toxoplasma’s Balancing Act Explained
Parasite’s method of rewiring our immune response leads to novel tool for drug tests.
T Cell Channel Could Be Targeted to Treat Cancers
Researcher identify ion-channel found within T cells that could be targeted to reduce development of neck and head cancers.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!